The patent covers the use of ISC-hpNSC®, ISCO’s proprietary neural stem cells derived from human parthenogenetic stem cells, for the treatment of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis. This patent also covers the use of neural cells derived from other human pluripotent stem cell sources, such as human embryonic stem cells (hESC) and induced pluripotent stem (iPS) cells.
International Stem Cell Corporation Grant... - Cure Parkinson's
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
I found the title, but I can't find the patent itself:
US10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of human neurodegenerative diseases.
Anyone else have more luck?
For anyone who might like some background information:
globenewswire.com/news-rele...
(this news release contains a link to a research paper)
Not what you're looking for?
You may also like...
Japanese stem cell treatment for Parkinson's set for US trials
slowing the disease's progress....
KARMET Study Begins Enrollment
administered, synthetic derivative of squalamine that acts locally on the enteric nerve cells of...
Parkinson’s disease stem cell therapy research update
case for stem cells for Parkinson’s....
Greetings From a New Member
exercise therapy and in the recent advancers in pluripotent cell therapy. Looking forward to...
Adipose fat derive stem cell treatment for Parkinson's
who does stem cell infusions to help with Parkinson's. The stem cell are adipose fat cells. They are